Midatech Pharma US Inc. - FORM 10-K - EX-23 - CONSENT OF ERNST & YOUNG LLP - March 9, 2010

Attached files

file filename
10-K - FORM 10-K - Midatech Pharma US Inc.d10k.htm
EX-21 - SUBSIDIARIES OF DARA BIOSCIENCES, INC. - Midatech Pharma US Inc.dex21.htm
EX-32 - SECTION 906 CEO AND CFO CERTIFICATION - Midatech Pharma US Inc.dex32.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Midatech Pharma US Inc.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Midatech Pharma US Inc.dex311.htm
EX-10.25 - STOCK PURCHASE AGREEMENT - Midatech Pharma US Inc.dex1025.htm

Exhibit 23

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-150150 and Form S-8 No. 333-150129) of our report dated March 9, 2010, with respect to the consolidated financial statements of DARA BioSciences, Inc. and subsidiaries included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

/s/ Ernst & Young LLP

Raleigh, North Carolina

March 9, 2010

Midatech Pharma US Inc. Reports